Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
NCT05642884

Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

Led by Noha Mohamed Sharafeldin · Updated on 2025-12-24

30

Participants Needed

1

Research Sites

181 weeks

Total Duration

On this page

Sponsors

N

Noha Mohamed Sharafeldin

Lead Sponsor

O

O'Neal Comprehensive Cancer Center at UAB

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.

CONDITIONS

Official Title

Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

Who Can Participate

Age: 60Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Multiple Myeloma
  • Scheduled for Autologous Stem Cell Transplant at UAB within 10 weeks of enrollment
  • Age 60 years or older at time of transplant
Not Eligible

You will not qualify if you...

  • High risk for impending pathologic fracture as determined by Mirels score

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kirklin Clinic of UAB Hospital

Birmingham, Alabama, United States, 35294

Actively Recruiting

Loading map...

Research Team

L

Landon Martin, BS

CONTACT

N

Noha Sharafeldin, MBBS PhD MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here